Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 22, 2022

Primary Completion Date

June 30, 2031

Study Completion Date

June 30, 2031

Conditions
SclerodermaSystemic Sclerosis
Interventions
DRUG

clopidogrel treatment

75 mg daily during 24 months

DRUG

Placebo

75 mg daily during 24 months

Trial Locations (10)

Unknown

RECRUITING

CH de la Cote Basque - service de rhumatologie, Bayonne

NOT_YET_RECRUITING

CHU de Bordeaux - service de Médecine Interne et Maladies Infectieuses, Bordeaux

RECRUITING

CHU de Bordeaux - service de rhumatologie, Bordeaux

RECRUITING

CHU de Brest - service de rhumatologie, Brest

NOT_YET_RECRUITING

CHU de Grenoble Alpes - service de médecine vasculaire, Grenoble

RECRUITING

CH de Libourne - service de rhumatologie, Libourne

RECRUITING

CH de Mont-de-Marsan - service de rhumatologie, Mont-de-Marsan

RECRUITING

AP-HP - Hôpital Cochin - service de médecine interne, Paris

RECRUITING

CH de Pau - service de médecine interne, Pau

NOT_YET_RECRUITING

CHU de Toulouse - service de médecine interne, Toulouse

All Listed Sponsors
collaborator

Ministry for Health and Solidarity, France

OTHER_GOV

lead

University Hospital, Bordeaux

OTHER